To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers
Status:
Completed
Trial end date:
2020-02-27
Target enrollment:
Participant gender:
Summary
This is a Phase I stage to investigate the safety and tolerability of MG-S-2525 in healthy
volunteers. The proposed trial consists of 3 study parts to be conducted at Tri-Service
General Hospital and includes Single Ascending Dose (SAD), Multiple Ascending Dose (MAD) and
Food Effect parts. This study will enroll up to 16 evaluable subjects in the SAD part, 36
evaluable subjects in the MAD part and enroll up to 20 evaluable subjects for the Food Effect
part.